Financials
- Financial year
- 2023
- Turnover
- €5.6m
- Loss
- -€3.5m
- Solvency
- 65.5%
Turnover▼ 64.0%
Net result
20182023
IQVIA MedTech NV
ActiveSummary
The computed 12-month bankruptcy probability of IQVIA MedTech NV is 2.1% (moderate). For IQVIA MedTech NV, at least two filing cycles of the annual accounts are missing. The 2023 annual accounts show equity of €34.2m and a net result of -€3.5m. Equity is growing by about 49% per year across the filed financial years. Its solvency ranks better than 74% of 1,096 sector peers (NACE 71, financial year 2023). The company has been active since 2005 and the Belgian Official Gazette contains no insolvency or warning signals.
Overview
Activity
Other technical testing and analysis
NACE 71209Other professional, scientific and technical activities NACE 74999
1 site
Size
€5.6mturnover 2023
- Staff
- 31.6 FTE
- Equity
- €34.2m
- Loss
- -€3.5m
Financial health
- Bankruptcy probabilitywithin 12 months
- 2.1%
2023 figures too old to score
Structure
- Parent
- IQVIA RDS & INTEGRATED SERVICES BELGIUM · 100%
- Emmanuel VanderhaegenDirector
- Clément VanthournhoutDirector
- Patrick Van DoorenDirector
Auditor: Mazars Bedrijfsrevisoren CV2024 accounts not filed, 456 days past the deadline5 of 31 deeds summarised
Signalsraises riskFigures for financial year 2023 (filed 24-12-2024)2 financial years not filed after the legal deadline; last filed accounts filed 145 days late; 2 of the last 3 lateLoss of €3.5m (financial year 2023)Two or more financial years not filed2023 accounts filed 145 days latelowers riskSector: Architectural and engineering activities; technical testing and analysis (NACE 71)Show the evidence
Bankruptcy probability
No current score
Figures too old
The available figures for FY 2023 are too old to assess current financial health.
Filing: At least two filing cycles are missing
Financial strength, FY 2023 · tick = 2022
Average
Solvency
90+18
equity 65.5% of total assets
Liquidity
47=
short-term debt 33.7% · cash 9.6%
Profitability
10-51
return on assets -6.8%
Bankruptcy probability, 12 months
2.1%
Moderate
0%0.5%1.5%4%10%≥ 25%
About 2 in 100 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
11-2024: 1.7%
12-2024: 1.7%● unchanged vs 11-2024
01-2025: 0.6%▼ -1.1 percentage points vs 12-2024
02-2025: 0.6%● unchanged vs 01-2025
03-2025: 0.6%● unchanged vs 02-2025
04-2025: 0.6%● unchanged vs 03-2025
05-2025: 0.5%▼ -0.1 percentage points vs 04-2025
06-2025: 0.5%● unchanged vs 05-2025
07-2025: 0.5%● unchanged vs 06-2025
08-2025: 0.7%▲ +0.2 percentage points vs 07-2025
09-2025: 0.4%▼ -0.3 percentage points vs 08-2025lowest value
10-2025: 0.5%▲ +0.1 percentage points vs 09-2025
11-2025: 0.6%▲ +0.1 percentage points vs 10-2025
12-2025: 0.7%▲ +0.1 percentage points vs 11-2025
01-2026: 1.5%▲ +0.8 percentage points vs 12-2025
02-2026: 1.5%● unchanged vs 01-2026
03-2026: 1.5%● unchanged vs 02-2026
04-2026: 1.3%▼ -0.2 percentage points vs 03-2026
05-2026: 1.3%● unchanged vs 04-2026
06-2026: 1.3%● unchanged vs 05-2026
07-2026: 1.3%● unchanged vs 06-2026
08-2026: 2.1%▲ +0.8 percentage points vs 07-2026highest value
09-2026: 2.1%● unchanged vs 08-2026highest value
10-2026: 2.1%● unchanged vs 09-2026
Credit check for your own amount and term
Show the recommended maximum and see how the verdict changes with amount, term and advance.
Signals
Six signals.
lowers riskraises risk
raises risk · Two or more financial years not filed
Since the financial year that closed on 31-12-2024, 2 financial years are missing at the National Bank. A company this far behind goes bankrupt within the year nineteen times as often as a punctual filer.
NBB · 8 filingsPosition against the passed deadline
31-12-2024 year end31-07-2025 deadline30-10-2026 today
raises risk · 2023 accounts filed 145 days late
The financial year that closed on 31-12-2023 was due by 31-07-2024 and was filed on 23-12-2024, 145 days past the deadline. Measured on financial year 2023: of the companies more than 90 days late, 5.61% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers.
NBB · 8 filingsDeviation from the deadline
2025
not filed
2024
not filed
2023
145 days late
2022
592 days late
2021
3 days early
2020
26 days early
2019
1 day early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 5 accounts on average 141 days after the deadline; the sector median (NACE 71) for financial year 2024 is 8 days before the deadline, and 34% of those companies filed late.
Searched, nothing found (1)
- Annual accounts filedfinancial year 2022 · full…
- Annual accounts filedfinancial year 2023 · full…
- Weakest financial yearnet -€3.5m
Key points
- Risk: 2024 accounts not fileddeadline was 31-07-2025 456 days past the deadline View
- Caution: From profit to loss in 2023after €575,833 in 2022 -€3.5m View
- Caution: Among the weakest 5% on net resultsector median €36,230 · 1,098 companies -€3.5m View
- Controlled by IQVIA RDS & INTEGRATED…ultimately: Ceuta Healthcare Limited 100% View
By topic
Board & ownership
- Board
- 3 members
- Parent
- IQVIA RDS & INTEGRATED… · 100%
- Auditor
- Mazars Bedrijfsrevisoren CV
- Emmanuel VanderhaegenDirector
- Clément VanthournhoutDirector
- Patrick Van DoorenDirector
Network & group
- Group
- Ceuta Healthcare Limited
Timeline
- Events
- 31
- Since
- 2007
- 31-12-2023Equity above €25m
- 03-08-2023Resignations: Wouter Tack (director) and Brad Thomas…
- 01-03-2023Resignation: Frank Swaelerıs (director)
Company details
- Sites
- 1
- Legal form
- Public limited company
- Activity
- Other technical testing and analysisNACE 71209
- Founded
- 18-05-2005
- Year ends
- 31-12
- Peppol
- Reachable for e-invoices
Articles of association
- Provisions read
- 1
See the provisions in the deeds
Go to Articles of associationKey facts about IQVIA MedTech NV
- What is the company number of IQVIA MedTech NV?
- 0873.863.003. In Belgium the VAT number is the company number with BE in front: BE 0873.863.003.
- Where is IQVIA MedTech NV based?
- The registered office is at Berchemstadionstraat 78, 2600 Antwerpen.Company details
- What does IQVIA MedTech NV do?
- According to the KBO register, the main activity is other technical testing and analysis (NACE 71209).
- What is the legal form of IQVIA MedTech NV?
- Public limited company (NV).
- When was IQVIA MedTech NV founded?
- On 18-05-2005.
- Is IQVIA MedTech NV still active?
- Yes, IQVIA MedTech NV is an active enterprise in the KBO register.
- How many employees does IQVIA MedTech NV have?
- On average 31.6 full-time equivalents in financial year 2023, according to the filed annual accounts.Financials
- What is the turnover of IQVIA MedTech NV?
- €5.6m in financial year 2023, according to the filed annual accounts.
- Is IQVIA MedTech NV profitable?
- In financial year 2023, IQVIA MedTech NV made a loss of €3.5m.
- Where can I find the annual accounts of IQVIA MedTech NV?
- IQVIA MedTech NV filed 20 annual accounts with the National Bank of Belgium, the latest for financial year 2023.
Companies related to IQVIA MedTech NV
Parent and group
Comparable companies
- Wimble Services BelgiumMechelen
- QUALITY ASSISTANCEThuin
- SGS BELGIUMAntwerpen
- VINÇOTTEVilvoorde
- IDEXX LABORATORIESBrussel
Go further with this company
How much credit can you give this customer, and on what payment terms?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.